首页> 外文期刊>Vaccine >The immunogenicity and safety of a tetravalent measles-mumps-rubella-varicella vaccine when co-administered with conjugated meningococcal C vaccine to healthy children: A phase IIIb, randomized, multi-center study in Italy
【24h】

The immunogenicity and safety of a tetravalent measles-mumps-rubella-varicella vaccine when co-administered with conjugated meningococcal C vaccine to healthy children: A phase IIIb, randomized, multi-center study in Italy

机译:四价麻疹-腮腺炎-风疹-水痘疫苗与健康的儿童联合使用脑膜炎球菌C结合疫苗的免疫原性和安全性:一项IIIb期,意大利的多中心随机研究

获取原文
获取原文并翻译 | 示例
           

摘要

Introduction: Multiple vaccination visits and administrations can be stressful for infants, parents and healthcare providers. Multivalent combination vaccines can deliver the required number of antigens in fewer injections and clinic visits, while vaccine co-administration can also reduce the number of visits. This non-inferiority study was undertaken to evaluate the feasibility of co-administering a combined measles-mumps-rubella-varicella (MMRV) vaccine with conjugated meningococcal C (MenC) vaccine in a large cohort of healthy Italian toddlers.
机译:简介:多次疫苗接种访问和给药会对婴儿,父母和医疗保健提供者造成压力。多价组合疫苗可以在较少的注射和临床就诊次数内提供所需数量的抗原,而疫苗共同给药也可以减少就诊次数。这项非劣效性研究旨在评估在大批健康的意大利幼儿中联合使用麻疹-腮腺炎-风疹-水痘(MMRV)疫苗和结合型脑膜炎球菌C(MenC)疫苗的可行性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号